Skip to content
10-K/A

Annual Report

TherapeuticsMD, Inc. TXMD

0001213900-25-037713

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 18, 2025 11.57M sh